Clinical Trials Logo
  1. Home
  2. Joint Pain
  3. NCT06444763

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

Joint Pain Clinical Trial

Official title:
Effect of Maolactin™ FMR Supplementation on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population: A Double-blind Randomized Placebo-controlled Study

Clinical Trial Summary

This is a double blind, randomised, placebo-controlled, parallel-group trial to evaluate the effect of Maolactin FMR supplementation on chronic inflammation, mobility and muscle and joint pain in an otherwise healthy population of adults 45-65 years old over 14 weeks with 12 weeks supplementation. This is PART B of the study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06444763
Study type Interventional
Source RDC Clinical Pty Ltd
Contact Amanda Rao, PhD
Phone +61 414 488 559
Email amanda@rdcglobal.com.au
Status Not yet recruiting
Phase Phase 3
Start date July 31, 2024
Completion date July 31, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT05052112 - Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Completed NCT04506411 - Turmeric Efficacy for Mobility and Joint Function N/A
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Completed NCT04408560 - Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer N/A
Completed NCT04150211 - Effects of Exten(d) Supplementation on Training Ability in Recreational Runners Phase 2
Completed NCT03209895 - Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain N/A
Withdrawn NCT01612728 - Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Phase 2
Completed NCT00691678 - Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer Phase 2
Recruiting NCT05212259 - Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects N/A
Recruiting NCT04182659 - Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms N/A
Terminated NCT04712019 - Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA N/A
Recruiting NCT06074744 - Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty N/A
Recruiting NCT00325845 - Synvisc Injections for Lumbar Facet Joint Pain Phase 3
Terminated NCT04872556 - Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients N/A
Active, not recruiting NCT03865992 - Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease N/A
Recruiting NCT05282992 - NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort N/A
Recruiting NCT04994249 - Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
Completed NCT01509079 - Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors Phase 2
Completed NCT04764110 - Short-term Impact of Cyplexinol® on Self-reported Joint Pain N/A